Sector: MedicalIcagen, Inc. (NASDAQ: ICGN)
Headlines
- Icagen Reports Third Quarter 2009 Financial Results and Operational Highlights
Nov 05, 2009 08:16 AM | ICGN, PFE
- Icagen Reports Top-line Results of Phase IIa Study of Senicapoc in Exercise-Induced Asthma
Oct 26, 2009 04:32 PM | ICGN
- Icagen to Report Third Quarter 2009 Results on November 5, 2009
Oct 26, 2009 08:16 AM | ICGN
- Icagen to Present at Eighth Annual Bio Investor Forum
Oct 20, 2009 08:16 AM | ICGN
- Icagen Describes Progress in Its Collaboration With Pfizer to Identify Selective Sodium Channel Inhibitors
Oct 19, 2009 04:39 PM | ICGN, PFE
- Icagen Announces Initiation of Proof-of-Mechanism Study of ICA-105665 in Pain
Sep 28, 2009 08:32 AM | ICGN
- Icagen Announces Initiation of Proof-of-Concept Study of ICA-105665 in Photosensitive Epilepsy
Sep 24, 2009 08:17 AM | ICGN
- Icagen Announces Extension of Pfizer Collaboration
Sep 21, 2009 08:16 AM | ICGN, PFE
- Stocks Fall at Mid-Day on Profit-Taking After Economic Data
Sep 01, 2009 01:50 PM | ACAD, AIG, ALU, BAC, EBAY, ICGN
- Icagen Reports Top Line Results of Phase IIa Study of Senicapoc in Allergic Asthma
Sep 01, 2009 08:03 AM | ICGN
- Icagen Reports Receipt of Notification from NASDAQ Regarding Non-Compliance With Continued Listing Requirements
Nov 13, 2009 05:13 PM | ICGN
- Icagen Reports Second Quarter 2009 Financial Results
Aug 04, 2009 08:01 AM | ICGN
- Icagen Announces Lifting of Partial Clinical Hold of ICA-105665
Aug 03, 2009 06:31 AM | ICGN
- Icagen to Report Second Quarter 2009 Results On August 4, 2009
Jul 23, 2009 08:02 AM | ICGN
- Dotmatics Has Licensed Its Browser Solution to Icagen
Jul 08, 2009 10:58 AM | ICGN
- Icagen Completes Enrollment in Phase II Exercise Induced Asthma Trial
Jun 12, 2009 08:01 AM | ICGN
- Icagen Provides Strategic Update
Jun 04, 2009 04:36 PM | ICGN
- Icagen Reports First Quarter 2009 Financial Results and Operational Highlights
May 05, 2009 08:03 AM | ICGN
- Icagen to Report First Quarter 2009 Results On May 5, 2009
Apr 24, 2009 08:01 AM | ICGN
- Icagen Completes Enrollment in Phase II Allergen Challenge Asthma Trial
Apr 23, 2009 08:01 AM | ICGN
- Form 4/A ICAGEN INC For: Sep 25 Filed by: Wagoner Kay (10K)
Nov 05, 2009 11:49 AM
- Form 4/A ICAGEN INC For: Jul 15 Filed by: Wagoner Kay (10K)
Nov 05, 2009 11:49 AM
- Form 4/A ICAGEN INC For: Jun 11 Filed by: Wagoner Kay (10K)
Nov 05, 2009 11:47 AM
- Form 4 ICAGEN INC For: Nov 02 Filed by: Katz Richard D (10K)
Nov 03, 2009 04:37 PM
- Form 4 ICAGEN INC For: Sep 14 Filed by: Katz Richard D (10K)
Sep 15, 2009 12:30 PM
- Form 4 HETHERINGTON SETH V For: Aug 17 (10K)
Aug 19, 2009 10:50 AM
- Form 4 ICAGEN INC For: Jul 15 Filed by: Wagoner Kay (10K)
Jul 15, 2009 04:28 PM
- Form 4 ICAGEN INC For: Jun 11 Filed by: Wagoner Kay (10K)
Jun 11, 2009 01:04 PM
- Form 4 EVNIN ANTHONY B For: Jun 03 (10K)
Jun 05, 2009 01:27 PM
- Form 4 GILLINGS DENNIS B PH D For: Jun 03 (10K)
Jun 05, 2009 01:26 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ICGN
|
Compare to S&P
|
| YTD |
-11.11 %
|
-26.43 %
|
| 4 Weeks |
-42.17 %
|
-42.79 %
|
| 12 Weeks |
-46.67 %
|
-49.72 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -40.00 %
|
|
EPS Growth in Last Year: 12.50 %
|
|
Sales Growth in Last Quarter: -0.13 %
|
|
Sales Growth in Last Quarter: -5.53 %
|
|
